Redefining reach: inclusivity gaps in UK phase 3 head and neck trial protocols over the last decade
Clicks: 1
ID: 325617
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #326 of 329 articles by views in JNCI Journal of the National Cancer Institute
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 329 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AIM: Inclusivity within head and neck cancer trials remains poorly characterised potentially limiting the applicability and validity of findings to under-represented groups. Using inclusive frameworks that enhance trial design and delivery for under-served groups we conducted a systematic review of Phase 3 UK-sponsored Head and Heck trial protocols over the last decade. METHODS: Head and Neck Phase 3 trial protocols registered between July 2014 to July 2024 were retrieved from the ISRCTN and ClinicalTrials.gov registries. Trial protocols were assessed using PRO-EDI (Patient-Reported Outcomes for Equity, Diversity, and Inclusion) and the NHIR INCLUDE framework, and findings summarized narratively. Participant characteristics collated included age, sex, race/ethnicity, socioeconomic status, education and disability. RESULTS: A total of 2,157 trial protocols were identified (2,029 ISRCTN and 128 Clinicaltrials.gov) and screened. Fourteen trial protocols met inclusion criteria for final analysis. Reporting of inclusion-related characteristics was inconsistent. Most trials (85.7%) imposed no upper age limit. Only 14.3% of trial protocols referenced ethnicity or socioeconomic status, and 28.6% mandated English proficiency without translation support. Only 28.6% trial protocols explicitly mention biological sex. None documented health literacy considerations or planned subgroup analyses. CONCLUSION: Overall, trial protocols demonstrated lack of inclusive considerations, underscoring the continued gap between policy and practice. The recently published NIHR's mandatory inclusion requirements, evolving standards in journal-led inclusive reporting in research trials and emerging initiatives akin to START-EDI, present opportunities to strengthen transparency, accountability and enhance representation in future head and neck cancer trials.
| Reference Key |
openalex_W7203753365
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yuri Hirayama, Shoba Dawson, Somiah Siddiq |
| Journal | JNCI Journal of the National Cancer Institute |
| Year | 2026 |
| DOI |
10.1093/jnci/djag283
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.